Management of Postpartum Hypermagnesemia
Immediately discontinue the magnesium sulfate infusion and administer intravenous calcium as the antidote—calcium chloride 10% (5-10 mL) or calcium gluconate 10% (15-30 mL) IV over 2-5 minutes—while providing supportive care with close monitoring of respiratory and cardiac function. 1, 2
Immediate Recognition and Discontinuation
The first critical step is recognizing magnesium toxicity and stopping the infusion. Hypermagnesemia presents with a predictable progression of clinical signs based on serum levels 1:
- At 2.5-5 mmol/L (5-10 mg/dL): ECG changes (prolonged PR, QRS, QT intervals)
- At 4-5 mmol/L (8-10 mg/dL): Loss of deep tendon reflexes, sedation, severe muscular weakness, respiratory depression
- At 6-10 mmol/L (12-20 mg/dL): AV nodal block, bradycardia, hypotension, cardiac arrest
Monitor for absent patellar reflexes as your bedside warning sign—reflexes typically disappear when magnesium exceeds 10 mEq/L, where respiratory paralysis becomes a real hazard 3.
Antidote Administration
Calcium is the specific antidote and should be immediately available whenever magnesium sulfate is being administered 1. The 2020 AHA guidelines provide clear dosing 2:
- Calcium chloride 10%: 5-10 mL IV over 2-5 minutes, OR
- Calcium gluconate 10%: 15-30 mL IV over 2-5 minutes
Calcium antagonizes both the CNS depression and peripheral transmission defects caused by magnesium 3. This is particularly lifesaving in the obstetric setting where iatrogenic overdose is possible, especially if the patient becomes oliguric 1.
Supportive Care and Monitoring
While calcium reverses the acute toxicity, supportive measures are essential:
- Respiratory support: Prepare for intubation if respiratory depression occurs (rate <16 breaths/min is concerning) 3
- Cardiac monitoring: Watch for bradycardia, arrhythmias, and hypotension
- Maintain urine output: Target ≥100 mL over 4 hours, as magnesium is eliminated solely by the kidneys 3
- Serial magnesium levels: Therapeutic range is 4.8-8.4 mg/dL (2.5-5 mEq/L for seizure control) 3
Special Considerations for Renal Impairment
Patients with renal dysfunction are at dramatically higher risk for toxicity 1. In severe renal impairment:
- Maximum dose should not exceed 20 g over 48 hours 3
- More frequent serum magnesium monitoring is mandatory
- Consider hemodialysis for severe, refractory hypermagnesemia with cardiopulmonary compromise 4—this rapidly removes magnesium when renal elimination is inadequate
Critical Pitfall: Unit Confusion
A dangerous and underrecognized source of error is misinterpretation of magnesium reporting units 5. Different laboratories report magnesium in different units (mg/dL vs. mEq/L), and failure to recognize this can lead to:
- Misdiagnosis of hypermagnesemia when levels are actually therapeutic
- Continued infusion when levels are already toxic
- Inappropriate dosing adjustments
Always verify which unit your laboratory uses and convert appropriately (1 mEq/L = approximately 2 mg/dL).
Duration of Postpartum Magnesium
While this addresses prevention rather than treatment of toxicity, standard practice continues 24 hours of postpartum magnesium sulfate for seizure prophylaxis 6, 7. The 2018 ISSHP guidelines acknowledge that shorter durations may be reasonable in select cases, but until more definitive evidence emerges, 24-hour postpartum continuation remains the standard 6.
For late postpartum severe hypertension (>48 hours after delivery), magnesium sulfate may not be warranted unless neurologic symptoms are present, as eclampsia at this stage is rare and typically preceded by warning signs 8.
Digitalized Patients
Exercise extreme caution if the patient is on digoxin—administering calcium to treat magnesium toxicity can cause serious cardiac conduction changes and heart block in digitalized patients 3. This requires careful cardiac monitoring and potentially cardiology consultation.